AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare Limited reported Q4FY26 revenue of Rs. 77 crore, up 7% YoY, and FY26 revenue of Rs. 288 crore, up 5% YoY. Net Profit grew strongly by 42% YoY to Rs. 15 crore in FY26, while Q4 PAT rose 28% to Rs. 5.5 crore. EBITDA for FY26 stood at Rs. 63 crore with margins at 22%, flat YoY. PAT margins improved to 5% in FY26 from 4% in FY25. The company highlighted ongoing capacity expansion for high-margin SteriPort and SVP products, and a captive solar power project for operational efficiency. CMD Bhavesh Patel emphasized disciplined execution and focus on scaling differentiated manufacturing technologies.
Strong bottom-line growth of 42% YoY with margin expansion signals improving earnings quality. The capacity expansion plans and focus on high-margin sterile liquid products position the company for sustainable growth, which could be positive for the stock.